Skip to content

Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients.

Alberto Amutio, Clemente Franco, María de Carmen Pérez-Fuentes, José J Gázquez, Isabel Mercader

Frontiers in Psychology January 12, 2015 DOI: 10.3389/fpsyg.2014.01572 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental trial with waiting list control group Peer reviewed
Population Women diagnosed with fibromyalgia
Intervention Mindfulness-based training program
Duration 7-week intervention, with follow-up 3 months after the end of the intervention
Topics Anxiety Depression Meditation
Keywords Fibromyalgia Anger
Key findings A seven-week mindfulness-based training program reduced trait anger, internal expression of anger, state anxiety, and depression and increased internal control of anger in women with fibromyalgia compared with a waiting-list control group; the authors report these changes were maintained three months after the intervention ended.

Abstract

Fibromyalgia is a disabling syndrome. Results obtained with different therapies are very limited to date. The goal of this study was to verify whether the application of a mindfulness-based training program was effective in modifying anger, anxiety, and depression levels in a group of women diagnosed with fibromyalgia. This study is an experimental trial that employed a waiting list control group. Measures were taken at three different times: pretest, posttest, and follow-up. The statistical analyses revealed a significant reduction of anger (trait) levels, internal expression of anger, state anxiety, and depression in the experimental group as compared to the control group, as well as a significant increase in internal control of anger. It can be concluded that the mindfulness-based treatment was effective after 7 weeks. These results were maintained 3 months after the end of the intervention.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 16

and 11 more in the library

Cites 9

and 4 more in the library

Explore topics